Spa-1 (Sipa1) and rap signaling in leukemia and cancer metastasis

Cancer Science

Volumn 100, Issue 1, 2009, Pages 17-23

  Minato, Nagahiro ^a   Hattori, Masakazu ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; PROTEIN SIPA1; PROTEIN SPA 1; RAP PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; B CELL LEUKEMIA; CANCER INVASION; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; GENETIC ENGINEERING; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; LEUKEMOGENESIS; LYMPHOCYTE; METASTASIS; MOLECULAR MECHANICS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T CELL LEUKEMIA;

ANIMALS; CELL LINEAGE; GTPASE-ACTIVATING PROTEINS; HUMANS; LEUKEMIA; LYMPHOCYTES; MICE; NEOPLASM METASTASIS; RAP GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 58149301362     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.01011.x     Document Type: Review

References (53)

1. Pizon V, Chardin P, Lerosey I, Olofsson B, Tavitian A. Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the 'effector' region. Oncogene 1988; 3: 201-4.
2. Bos JL, de Rooij J, Reedquist KA. Rap1 signalling: Adhering to new models. Nat Rev Mol Cell Biol 2001; 2: 369-77.
3. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M. A ras-related gene with transformation suppressor activity. Cell 1989; 56: 77-84.
4. Yoshida Y, Kawata M, Miura Y et al. Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol Cell Biol 1992; 12: 3407-14.
5. Altschuler DL, Ribeiro-Neto F. Mitogenic and oncogenic properties of the small G protein Rap1b. Proc Natl Acad Sci USA 1998; 95: 7475-9.
6. Hattori M, Minato N. Rap1 GTPase: Functions, regulation, and malignancy. J Biochem (Tokyo) 2003; 134: 479-84.
7. Sasagawa S, Ozaki Y, Fujita K, Kuroda S. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat Cell Biol 2005; 7: 365-73.
8. Tsukamoto N, Hattori M, Yang H, Bos JL, Minato N. Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion. J Biol Chem 1999; 274: 18463-9.
9. Stork PJ, Dillon TJ. Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions. Blood 2005; 106: 2952-61.
10. Minato N, Kometani K, Hattori M. Regulation of immune responses and hematopoiesis by the Rap1 signal. Adv Immunol 2007; 93: 229-64.
11. Katagiri K, Hattori M, Minato N, Irie S, Takatsu K, Kinashi T. Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol Cell Biol 2000; 20: 1956-69.
12. Bos JL. Linking Rap to cell adhesion. Curr Opin Cell Biol 2005; 17: 123-8.
13. Katagiri K, Maeda A, Shimonaka M, Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol 2003; 4: 741-8.
14. Arthur WT, Quilliam LA, Cooper JA. Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors. J Cell Biol 2004; 167: 111-22.
15. Lafuente EM, van Puijenbroek AA, Krause M et al. RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev Cell 2004; 7: 585-95.
16. Hogan C, Serpente N, Cogram P et al. Rap1 regulates the formation of E-cadherin-based cell-cell contacts. Mol Cell Biol 2004; 24: 6690-700.
17. Hoshino T, Sakisaka T, Baba T, Yamada T, Kimura T, Takai Y. Regulation of E-cadherin endocytosis by nectin through afadin, Rap1, and p120ctn. J Biol Chem 2005; 280: 24095-103.
18. Kometani K, Moriyama M, Nakashima Y et al. Essential role of Rap signal in pre-TCR-mediated β-selection checkpoint in αβ T cell development. Blood 2008; Sep. 18 on-line ahead of print.
19. Ciofani M, Schmitt TM, Ciofani A et al. Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. J Immunol 2004; 172: 5230-9.
20. Maillard I, Tu L, Sambandam A et al. The requirement for Notch signaling at the β-selection checkpoint in vivo is absolute and independent of the pre-T cell receptor. J Exp Med 2006; 203: 2239-45.
21. Hattori M, Tsukamoto N, Nur-e-Kamal MS et al. Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression. Mol Cell Biol 1995; 15: 552-60.
22. Wada Y, Kubota H, Maeda M et al. Mitogen-inducible SIPA1 is mapped to the conserved syntenic groups of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human. Genomics 1997; 39: 66-73.
23. Kurachi H, Wada Y, Tsukamoto N et al. Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rap1GAP gene product. J Biol Chem 1997; 272: 28081-8.
24. Ishida D, Kometani K, Yang H et al. Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice. Cancer Cell 2003; 4: 55-65.
25. Kometani K, Aoki M, Kawamata S et al. Role of SPA-1 in phenotypes of CML induced by BCR-ABL-expressing hematopoietic progentiors in mouse model. Cancer Res 2006; 66: 9967-76.
26. Ishida D, Yang H, Masuda K et al. Antigen-driven T cell anergy and defective memory T cell response via deregulated Rap1 activation in SPA-1-deficient mice. Proc Natl Acad Sci USA 2003; 100: 10919-24.
27. Calabretta B, Perrotti D. The biology of CML blast crisis. Blood 2004; 103: 4010-22.
28. Cho YJ, Hemmeryckx B, Groffen J, Heisterkamp N. Interaction of Bcr/Abl with C3G, an exchange factor for the small GTPase Rap1, through the adapter protein Crkl. Biochem Biophys Res Commun 2005; 333: 1276-83.
29. Jin A, Kurosu T, Tsuji K et al. BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion. Oncogene 2006; 25: 4332-40.
30. Ishida D, Su L, Tamura A et al. Rap1 signal controls B cell receptor repertoire and generation of self-reactive B1a cells. Immunity 2006; 24: 417-27.
31. Yurasov S, Nussenzweig MC. Regulation of autoreactive antibodies. Curr Opin Rheumatol 2007; 19: 421-6.
32. Wang SF, Aoki M, Nakashima Y et al. Development of Notch-dependent T-cell leukemia by deregulated Rap1 signaling. Blood 2008; 111: 2878-86.
33. Grabher C, von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006; 6: 347-59.
34. Weng AP, Ferrando AA, Lee W et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269-71.
35. Dumortier A, Jeannet R, Kirstetter P et al. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol 2006; 26: 209-20.
36. Lin YW, Nichols RA, Letterio JJ, Aplan PD. Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood 2006; 107: 2540-3.
37. O'Neil J, Calvo J, McKenna K et al. Activating Notch1 mutations in mouse models of T-ALL. Blood 2006; 107: 781-5.
38. O'Neil J, Grim J, Strack P et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007; 204: 1813-24.
39. Allman D, Karnell FG, Punt JA et al. Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J Exp Med 2001; 194: 99-106.
40. Yajnik V, Paulding C, Sordella R et al. DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell 2003; 112: 673-84.
41. Itoh M, Nelson CM, Myers CA, Bissell MJ. Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells. Cancer Res 2007; 67: 4759-66.
42. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol 1992; 12: 954-61.
43. Lifsted T, Le Voyer T, Williams M et al. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 1998; 77: 640-4.
44. Lancaster M, Rouse J, Hunter KW. Modifiers of mammary tumor progression and metastasis on mouse chromosomes 7, 9, and 17. Mamm Genomeaaa 2005; 16: 120-6.
45. Park YG, Zhao X, Lesueur F et al. Sipa1 is a candidate for underlying the metastasis efficiency modifier locus. Mtes1 Nat Genet 2005; 37: 1055-62.
46. Threadgill DW. Metastatic potential as a heritable trait. Nat Genet 2005; 37: 1026-7.
47. Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res 2006; 8: R16.
48. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33: 49-54.
49. Crawford NP, Walker RC, Lukes L, Officewala JS, Williams RW, Hunter KW. The Diasporin Pathway: A tumor progression-related transcriptional network that predicts breast cancer survival. Clin Exp Metastasis 2008; 25: 357-69.
50. Crawford NP, Qian X, Ziogas A et al. Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 2007; 3: E214.
51. Crawford NP, Alsarraj J, Lukes L et al. Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci USA 2008; 105: 6380-5.
52. Maruyama T, Farina A, Dey A et al. A mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase. Mol Cell Biol 2002; 22: 6509-20.
53. Farina A, Hattori M, Qin J, Nakatani Y, Minato N, Ozato K. Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization. Mol Cell Biol 2004; 24: 9059-69.